Clinical Trial Update: Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia [NA]

View source ↗

Summary

This clinical trial update describes a planned study of CLL-1–targeted CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for relapsed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CLL-1 CAR-T

Snippet

Sponsor: Donghua Zhang | Conditions: AML, AML (Acute Myeloid Leukemia) | NA | Status: NOT_YET_RECRUITING